July 16, 2019
Results: Arbutus Biopharma’s AB-506 is a potent capsid inhibitor
Arbutus Biopharma’s AB-506 is a potent oral capsid inhibitor, preliminary results from testing have shown, the company said Monday.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
July 11, 2019
Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being
Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…
July 11, 2019
Gerresheimer quarterly net income up to €47.1M
Gerresheimer AG has had a successful second quarter, en route to meeting all of its targets for 2019, Dietmar Siemssen, the CEO, has said in a press release Tursday.
July 11, 2019
Tilray® Imports GMP-Certified Standardized Medical Cannabis Oil Into Ireland
Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need
July 10, 2019
BioNTech Raises $325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
BioNTech pulled one of the largest private EU biotech funding events expands global shareholder base with $325 from investors
July 9, 2019
Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being
Microphyt secures one of the largest fundraising in the microalgae sector; The round was co-led by Sofinnova Partners and Bpifrance…
July 9, 2019
Neovacs gets payment for AllergyVacs, from National Agency for Research
Neovacs has received a first payment of a total amount up to €702.000, for its preclinical development program AllergyVacs, within the grant awarded by the National Agency for Research (ANR), conducted in collaboration with Inserm and the Immunology and Allergy Department of Pasteur Institute.
July 9, 2019
Dilafor enrolls the first patient to test tafoxiparin in certain pregnant women
Karolinska Development’s drug developer Dilafor AB, focused on tafoxiparin for obstetric indications, has enrolled the first subject in its Phase 2b study with tafoxiparin in pregnant women planned for labor induction, Karolinska said Tuesday in a press release.
July 9, 2019
Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market
Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets
July 9, 2019
Dabigatran’s safety and efficacy established for management of VTE in children
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.